Halobetasol Propionate

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

20 Suppliers, 9 USDMF, 2 EU WC, 6 NDC API, 17 Listed Suppliers

DEVELOPMENTS

5 Drug(s) in Development

5 Drug(s) in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Exports

DOSSIERs // Finished Dosage Forms

26 Dossiers, 20 FDA Orange Book, 4 Canada, 2 Listed Dossiers

DRUG PRODUCT COMPOSITION

CREAM;TOPICAL - 0.05% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, OINTMENT;TOPICAL - 0.05% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, AEROSOL, FOAM;TOPICAL - 0.05%

RELATED EXCIPIENT COMPANIES

Suppliers, 6 BASF, 2 Nanjing Well Pharmaceutical, 2 Actylis, 2 Corel Pharma Chem, 2 Lubrizol Life Science Health, 1 Gangwal Chemicals, 1 Microlex e.U, 1 Finar, 1 Nanjing Bold Chemical, 1 Kerry

EXCIPIENTS BY APPLICATIONS

10 Topical, 5 Thickeners and Stabilizers, 4 Solubilizers, 4 Parenteral, 2 Film Formers & Plasticizers, 2 Granulation, 2 Lubricants & Glidants, 2 Direct Compression, 1 Controlled & Modified Release, 1 Surfactant & Foaming Agents, 1 Fillers, Diluents & Binders, 1 Chewable & Orodispersible Aids, 1 Emulsifying Agents, 1 Coating Systems & Additives

GLOBAL SALES INFORMATION

27 US Medicaid Prescriptions, 6 Finished Drug Prices

MARKET PLACE

7 APIs

7 APIs

PATENTS

14 US Patents, 2 US Exclusivities

ANALYTICAL SOLUTION(s)

1 USP Standards, 1 Other Ref. Standards

DIGITAL CONTENT

27 News

27 News

Information, Expiry, & Status of FDA Orange Book Exclusivities covering Halobetasol Propionate

Halobetasol Propionate

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

20 Suppliers

9 USDMF

2 EU WC

6 NDC API

17 Listed Suppliers

DEVELOPMENTS

5 Drug(s) in Development

PRICE INFORMATION

API Reference Price

API Exports

API Imports

FDF Exports

DOSSIERs // Finished Dosage Forms

26 Dossiers

20 FDA Orange Book

4 Canada

2 Listed Dossiers

DRUG PRODUCT COMPOSITION

CREAM;TOPICAL - 0.05% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

OINTMENT;TOPICAL - 0.05% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

AEROSOL, FOAM;TOPICAL - 0.05%

RELATED EXCIPIENT COMPANIES

Suppliers

6 BASF

2 Nanjing Well Pharmaceutical

2 Actylis

2 Corel Pharma Chem

2 Lubrizol Life Science Health

1 Gangwal Chemicals

1 Microlex e.U

1 Finar

1 Nanjing Bold Chemical

1 Kerry

EXCIPIENTS BY APPLICATIONS

10 Topical

5 Thickeners and Stabilizers

4 Solubilizers

4 Parenteral

2 Film Formers & Plasticizers

2 Granulation

2 Lubricants & Glidants

2 Direct Compression

1 Controlled & Modified Release

1 Surfactant & Foaming Agents

1 Fillers, Diluents & Binders

1 Chewable & Orodispersible Aids

1 Emulsifying Agents

1 Coating Systems & Additives

GLOBAL SALES INFORMATION

27 US Medicaid Prescriptions

6 Finished Drug Prices

MARKET PLACE

7 APIs

PATENTS

14 US Patents

2 US Exclusivities

ANALYTICAL SOLUTION(s)

1 USP Standards

1 Other Ref. Standards

DIGITAL CONTENT

27 News

Halobetasol Propionate

MAYNE PHARMA

HALOBETASOL PROPIONATE

NPP

2024-08-18

210566

1

PADAGIS ISRAEL

HALOBETASOL PROPIONATE

PC

2024-06-24

215266

1

CREAM;TOPICAL - 0.05% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

OINTMENT;TOPICAL - 0.05% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons